These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31774538)

  • 41. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
    Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Other autoinflammatory disease genes in an FMF-prevalent population: a homozygous MVK mutation and a novel heterozygous TNFRSF1A mutation in two different Turkish families with clinical FMF.
    Karacan İ; Uğurlu S; Tolun A; Tahir Turanlı E; Ozdogan H
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):75-81. PubMed ID: 29148404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "Periodic fever" without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis.
    Kallinich T; Haffner D; Rudolph B; Schindler R; Canaan-Kühl S; Keitzer R; Burmester GR; Roesen-Wolff A; Roesler J
    Ann Rheum Dis; 2006 Jul; 65(7):958-60. PubMed ID: 16308343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.
    Aguado-Gil L; Irarrazaval-Armendáriz I; Pretel-Irazabal M
    Actas Dermosifiliogr; 2013 Sep; 104(7):617-22. PubMed ID: 23891452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome.
    Rigante D; Lopalco G; Vitale A; Lucherini OM; De Clemente C; Caso F; Emmi G; Costa L; Silvestri E; Andreozzi L; Iannone F; Galeazzi M; Cantarini L
    Clin Rheumatol; 2014 Sep; 33(9):1197-207. PubMed ID: 24935411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brief Report: Association of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome With Gonosomal Mosaicism of a Novel 24-Nucleotide TNFRSF1A Deletion.
    Rowczenio DM; Trojer H; Omoyinmi E; Aróstegui JI; Arakelov G; Mensa-Vilaro A; Baginska A; Silva Pilorz C; Wang G; Lane T; Brogan P; Hawkins PN; Lachmann HJ
    Arthritis Rheumatol; 2016 Aug; 68(8):2044-9. PubMed ID: 26992170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults.
    Cantarini L; Iacoponi F; Lucherini OM; Obici L; Brizi MG; Cimaz R; Rigante D; Benucci M; Sebastiani GD; Brucato A; Sabadini L; Simonini G; Giani T; Laghi Pasini F; Baldari CT; Bellisai F; Valentini G; Bombardieri S; Paolazzi G; Galeazzi M
    Int J Immunopathol Pharmacol; 2011; 24(3):695-702. PubMed ID: 21978701
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A family of tumor necrosis factor receptor-associated periodic syndrome].
    Li S; Ou RQ; Zhang BH; Zhang YN; Wang HY; Tan WP
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):477-482. PubMed ID: 31216807
    [No Abstract]   [Full Text] [Related]  

  • 49. Circulating intercellular adhesion molecule 1 (sICAM-1) in tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
    Cantarini L; Pucino V; Vitale A; Lucherini OM; Obici L; Matarese G
    Clin Exp Rheumatol; 2017; 35 Suppl 104(2):13-14. PubMed ID: 28375838
    [No Abstract]   [Full Text] [Related]  

  • 50. Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
    La Torre F; Muratore M; Vitale A; Moramarco F; Quarta L; Cantarini L
    Rheumatol Int; 2015 Nov; 35(11):1943-7. PubMed ID: 26048626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autosomal dominant familial periodic fever patient with a missense variant c.215G>A (p.Cys72Tyr) in TNFRSF1A gene presenting as neutrophilia.
    Rajpal S; Jamwal M; Lad D; Das R
    Eur J Med Genet; 2021 May; 64(5):104191. PubMed ID: 33753323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical analysis of 10 cases of multi-center tumor necrosis factor receptor-associated periodic syndrome].
    Ma MS; Yang Z; Zhang CH; Shangguan YY; Li YZ; Zhu MF; Bai C; Zhou Y; Zhang QY; Yu HG; Wu XC; Zheng WJ; Yang J; Song HM
    Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1098-1102. PubMed ID: 38018047
    [No Abstract]   [Full Text] [Related]  

  • 53. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever.
    Nevala H; Karenko L; Stjernberg S; Raatikainen M; Suomalainen H; Lagerstedt A; Rauta J; McDermott MF; Peterson P; Pettersson T; Ranki A
    Arthritis Rheum; 2002 Apr; 46(4):1061-6. PubMed ID: 11953985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TNFRSF1A Gene Causing Tumor Necrosis Factor Receptor-associated Periodic Syndrome in 2 Siblings Displaying Variable Disease Severity and Discordant Heterozygosity for an MEFV E148Q Variant.
    Abdwani R; Abdalla E; Al Abrawi S; Al-Thihli K
    J Rheumatol; 2015 Aug; 42(8):1534-5. PubMed ID: 26233954
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
    Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
    Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives.
    Cantarini L; Lucherini OM; Muscari I; Frediani B; Galeazzi M; Brizi MG; Simonini G; Cimaz R
    Autoimmun Rev; 2012 Nov; 12(1):38-43. PubMed ID: 22884554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Progress in classification and treatment for TNF receptor-associated periodic syndrome].
    Tsukamoto H; Ueda N; Horiuchi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):361-8. PubMed ID: 22041423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers.
    Aksentijevich I; Galon J; Soares M; Mansfield E; Hull K; Oh HH; Goldbach-Mansky R; Dean J; Athreya B; Reginato AJ; Henrickson M; Pons-Estel B; O'Shea JJ; Kastner DL
    Am J Hum Genet; 2001 Aug; 69(2):301-14. PubMed ID: 11443543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor necrosis factor receptor-associated periodic syndrome in a pediatric patient: A genetic diagnosis.
    Yakhmi N; Knutsen AP
    Ann Allergy Asthma Immunol; 2020 Oct; 125(4):369-371. PubMed ID: 32376455
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.